Trastornos del metabolismo de los lípidos: Revisión de las indicaciones de los productos dietéticos libres de grasa y alternativas de nutrición con alimentos de consumo ordinario (Inform nº: Osteba E-13-06)

Lymphangiectasis; Intestinal (C15.604.360.500); Wolman Disease (C18.452.584.687.201.500); Hypobetalipoproteinemia; Familial; Apolipoprotein B (C18.452.584.500.875.440.750); Abetalipoproteinemia (C18.452.584.500.875.440.500); Hypobetalipoproteinemias (C18.452.648.398.500.440); Mitochondrial Myopathies (C18.452.660.560); Apolipoprotein C-I (D12.776.070.400.400.500); Acyltransferases (D08.811.913.050); Carnitine Acyltransferases (D08.811.913.050.350); Lipids (D10); Diet (G07.610.240); Nutrition Assessment (E05.318.308.585)

Lipid metabolism disorders: Review of the indications of fat free dietetic products and nutritional alternatives with regularly consumed foodstuffs

2013